Evidence map›Paper›PMID 42028181›Full record

ArticleDose-response : a publication of International Hormesis Society

Quercetin Alleviates Renal Ischemia-Reperfusion Injury by Inhibiting the STING-NF-κB Inflammatory Pathway.

Chunchu Zou, Miao Ye

Abstract read
In one paragraph

Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Chunchu ZouDepartment of Pharmacy, Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, P.R.China.ORCID https://orcid.org/0009-0001-6084-477X
Miao YeDepartment of Pharmacy, Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People's Hospital, Lishui, Zhejiang, P.R.China.ORCID https://orcid.org/0009-0005-7833-7302

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Ischemic/reperfusion (I/R) injury seriously affects human health. Renal tubular epithelial cell injury and inflammation are important pathogenic mechanisms involved in I/R injury. Recent studies have shown that quercetin (QU) is one of the most effective natural products against inflammatory responses and is mainly used as an adjuvant treatment for chronic diseases in clinical practice. However, the effect of QU on renal I/R injury remains unclear. Methods: The therapeutic effect of QU was evaluated in a mouse model of renal I/R injury in vivo, and its anti-inflammatory mechanisms were preliminarily investigated in Normal Rat Kidney-52E (NRK-52E) cells. Subsequently, STING knockout mice were used to verify the anti-inflammatory mechanism. Results: Our results showed that QU alleviates renal injury and inflammation subsequent to I/R. In vitro, QU alleviated inflammatory responses induced by H Conclusion: These results demonstrated that QU protected against renal I/R injury by suppressing inflammation via the STING-NF-κB axis, highlighting its therapeutic potential.

Indexed as

inflammationischemic reperfusion injuryNF-κBquercetinSTING

Identifiers

PMID42028181
PMCPMC13100409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.